FIRST-LINE DASATINIB PLUS CONVENTIONAL CHEMOTHERAPY IN ADULTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: THE KOREAN PROSPECTIVE PHASE II STUDY

被引：0
|
作者：
Lee, S. [1 ]
Kim, D. W. [1 ]
Kim, Y. J. [1 ]
Yhim, H. Y. [2 ]
Kwak, J. Y. [2 ]
Yang, D. H. [3 ]
Lee, J. J. [3 ]
Kim, S. J. [4 ]
Kim, J. S. [4 ]
Park, S. J. [5 ]
Choi, C. W. [5 ]
Eom, H. S. [6 ]
Park, S. K. [7 ]
Lee, J. W. [1 ]
Min, W. S. [1 ]
Park, C. W. [1 ]
机构：
[1] Catholic Univ Korea, Catholic BMT Ctr, Seoul, South Korea
[2] Chonbuk Natl Univ, Sch Med, Jeonju, South Korea
[3] Chonnam Natl Univ, Hwasun Hosp, Hwasun Gun, Jeollanamdo, South Korea
[4] Yonsei Univ, Coll Med, Seoul, South Korea
[5] Korea Univ, Coll Med, Seoul, South Korea
[6] Natl Canc Ctr, Ilsan, South Korea
[7] Soonchunhyang Univ, Sch Med, Bucheon, South Korea
来源：
HAEMATOLOGICA | 2012年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1123
引用
收藏
页码：462 / 463
页数：2
相关论文
共 50 条
  • [1] First-Line Dasatinib Plus Conventional Chemotherapy in Adults with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL): Interim Analysis of the Korean Prospective Phase II Study
    Lee, Seok
    Kim, Dong-Wook
    Kim, Yoo-Jin
    Yhim, Ho-Young
    Kwak, Jae-Yong
    Yang, Deok-Hwan
    Lee, Je-Jung
    Kim, Soo-Jeong
    Kim, Jin-Seok
    Park, Seh Jong
    Choi, Chul Won
    Lee, Jong-Wook
    Min, Woo-Sung
    Park, Chong-Won
    BLOOD, 2011, 118 (21) : 658 - 658
  • [2] Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
    Foa, Robin
    Vitale, Antonella
    Vignetti, Marco
    Meloni, Giovanna
    Guarini, Anna
    De Propris, Maria Stefania
    Elia, Loredana
    Paoloni, Francesca
    Fazi, Paola
    Cimino, Giuseppe
    Nobile, Francesco
    Ferrara, Felicetto
    Castagnola, Carlo
    Sica, Simona
    Leoni, Pietro
    Zuffa, Eliana
    Fozza, Claudio
    Luppi, Mario
    Candoni, Anna
    Iacobucci, Ilaria
    Soverini, Simona
    Mandelli, Franco
    Martinelli, Giovanni
    Baccarani, Michele
    BLOOD, 2011, 118 (25) : 6521 - 6528
  • [3] A phase II trial of ponatinib and blinatumomab in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph plus ALL)
    Short, Nicholas James
    Jabbour, Elias
    Jain, Nitin
    Macaron, Walid
    Huang, Xuelin
    Montalban-Bravo, Guillermo
    Kadia, Tapan M.
    Daver, Naval Guastad
    Haddad, Fadi
    Zoghbi, Marianne
    Nasnas, Cedric Christophe
    Nasr, Lewis Fady
    Mayor, Ejiroghene
    Deen, Wuliamatu
    Thankachan, Jennifer
    Loiselle, Christopher
    Garris, Rebecca
    Konopleva, Marina
    Ravandi, Farhad
    Kantarjian, Hagop M.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] Imatinib plus combination chemotherapy for newly-diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Lee, KH
    Choi, SJ
    Lee, JH
    Seol, M
    Lee, YS
    Kim, S
    Park, CJ
    Chi, HS
    Kim, WK
    Lee, JS
    Lee, JH
    BLOOD, 2003, 102 (11) : 884A - 884A
  • [5] Impact of the addition of rituximab in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia
    Rios-Olais, Fausto Alfredo
    Rodriguez-Rodriguez, Sergio
    Mora-Canas, Analy
    Ramos-Penafiel, Christian Omar
    Urbalejo-Ceniceros, Victor Itai
    Lopez-Garcia, Yadith Karina
    Gomez-De Leon, Andres
    Delgado-Lopez, Nancy
    Castellanos-Mares, Mistral
    Figueroa-Hernandez, Patricia Carolina
    Demichelis-Gomez, Roberta
    LEUKEMIA & LYMPHOMA, 2025, 66 (03) : 561 - 564
  • [6] Dasatinib combined with multi-agent chemotherapy regimen in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia a prospective study from a single center
    张广吉
    ChinaMedicalAbstracts(InternalMedicine), 2021, 38 (02) : 119 - 120
  • [7] Dasatinib as an investigational drug for the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in adults
    Brattas, Marte Karen
    Reikvam, Hakon
    Tvedt, Tor Henrik Anderson
    Bruserud, Oystein
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (05) : 411 - 420
  • [8] The effect of first-line imatinib interim therapy on the outcome of allogeneic stem cell transplantation in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia
    Lee, S
    Kim, YJ
    Min, CK
    Kim, HJ
    Eom, KS
    Kim, DW
    Lee, JW
    Min, WS
    Kim, CC
    BLOOD, 2005, 105 (09) : 3449 - 3457
  • [9] Chemotherapy-Free Combination of Blinatumomab and Ponatinib in Adults with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Updates from a Phase II Trial
    Haddad, Fadi G.
    Jabbour, Elias
    Short, Nicholas J.
    Jain, Nitin
    Huang, Xuelin
    Montalban-Bravo, Guillermo
    Kadia, Tapan M.
    Daver, Naval
    Nasnas, Cedric
    Mayor, Ejiroghene
    Nasnas, Patrice Eric
    Deen, Wuliamatu
    Zoghbi, Marianne
    Thankachan, Jennifer
    Loiselle, Christopher
    Garris, Rebecca
    Ravandi, Farhad
    Kantarjian, Hagop M.
    BLOOD, 2023, 142
  • [10] yInterim Results of a Phase II Study of Dasatinib and Prednisone As an Oral, Chemo-Free Induction and Consolidation Regimen for Adults with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    Xie, Mixue
    Lu, Ying
    Ouyang, Guifang
    Zhang, Liming
    Hu, Huixian
    Shi, Ting
    Li, Xueying
    Ye, Xiujing
    Jin, Jie
    Zhu, Hong-Hu
    BLOOD, 2021, 138
12345